Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets [v2; ref status: indexed, http://f1000r.es/35d]
Innovative drug discovery approaches are currently needed to rejuvenate the shrinking product pipelines of the pharmaceutical companies across the globe. Here a theme is presented – the use of central nervous system (CNS) drugs as leads for non-CNS targets. The approach is related to the use of exis...
Main Author: | Prashant S. Kharkar |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2014-03-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | http://f1000research.com/articles/3-40/v2 |
Similar Items
-
Drugs acting on central nervous system (CNS) targets as leads for non-CNS targets [v1; ref status: indexed, http://f1000r.es/2wf]
by: Prashant S. Kharkar
Published: (2014-02-01) -
A brief review of recent Charcot-Marie-Tooth research and priorities [v1; ref status: indexed, http://f1000r.es/53g]
by: Sean Ekins, et al.
Published: (2015-02-01) -
Short- and long-term habituation of auditory event-related potentials in the rat [v2; ref status: indexed, http://f1000r.es/3dv]
by: Kestutis Gurevicius, et al.
Published: (2014-05-01) -
Short- and long-term habituation of auditory event-related potentials in the rat [v1; ref status: indexed, http://f1000r.es/1l3]
by: Kestutis Gurevicius, et al.
Published: (2013-09-01) -
Positive or negative allosteric modulation of metabotropic glutamate receptor 5 (mGluR5) does not alter expression of behavioral sensitization to methamphetamine [v1; ref status: indexed, http://f1000r.es/o0]
by: Peter R Kufahl, et al.
Published: (2013-03-01)